The article is focused on current state of diagnosis of IDH-mutant gliomas in Russia: potential of predictive neuroimaging, intraoperative mass spectrometry, traditional immunohistochemistry and molecular analysis of paraffin-embedded glioma tissue and targeted therapy with FDA-approved IDH inhibitors.
No takes yet. Share an insight, caveat, or question.
Marina Vladimirovna Ryzhova (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: